Biotech Roundup: ZymoGenetics, GlaxoSmithKline, Amgen...

Minyanville.com - New York,USA
Only the counterbalance caused by the patent-expiration driven need for
pharma and biopharma to acquire development-stage biotech companies makes
the sector ...

http://www.minyanville.com/articles/FDA-AMGN-PFE-ADLR-GSK-ZGEN-DNA-OMRI/ind
ex/a/14102

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.minyanville.com/articles/F
DA-AMGN-PFE-ADLR-GSK-ZGEN-DNA-OMRI/index/a/14102



Biotech News
AZhttp, Inc.
Biotechnology Marketing